Immunology: A genetic signature for TB

A newly developed genetic biomarker could aid the development of diagnostic and prognostic tools for tuberculosis (TB), a Nature study suggests.

Immunology: A genetic signature for TB

DOI: 10.1038/nature09247

A newly developed genetic biomarker could aid the development of diagnostic and prognostic tools for tuberculosis (TB), a Nature study suggests.

Anne O’Garra and colleagues analysed the genomes of people with active TB, latent TB (infected but asymptomatic) and healthy controls to produce a so-called transcriptional profile of expressed genes related to the disease. This genetic signature correlates with radiological extent of the disease.

Only around 10% of people with latent TB go on to develop the active disease, but current tests cannot identify those at risk. In this study, around 10% of latent patients displayed the ‘active disease’ transcriptional signature, suggesting that the biomarker may prove useful prognostically as well as diagnostically.

The immune response to the TB-causing microbe Mycobacterium tuberculosis is complex and incompletely characterized, and this study also sheds light on this area. The TB signature is dominated by an interferon-inducible gene profile, which is most evident in neutrophils, white blood cells that form an essential part of our innate immune system.

Author contact
Anne O’Garra (MRC National Institute for Medical Research, London, UK)
Tel: +44 20 8816 2508
E-mail: [email protected]

PRESS CONTACTS…

From North America and Canada
Neda Afsarmanesh, Nature New York
Tel: +1 212 726 9231
E-mail: [email protected]

From Japan, Korea, China, Singapore and Taiwan
Mika Nakano, Nature Tokyo
Tel: +81 3 3267 8751
E-mail: [email protected]

From the UK
Rebecca Walton, Nature, London
Tel: +44 20 7843 4502
E-mail: [email protected]

About Nature Publishing Group (NPG):

Nature Publishing Group (NPG) is a publisher of high impact scientific and medical information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences and clinical medicine.

Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. In addition, for this audience, NPG publishes a range of Nature research journals and Nature Reviews journals, plus a range of prestigious academic journals including society-owned publications. Online, nature.com provides over 5 million visitors per month with access to NPG publications and online databases and services, including Nature News and NatureJobs plus access to Nature Network and Nature Education’s Scitable.com.

Scientific American is at the heart of NPG’s newly-formed consumer media division, meeting the needs of the general public. Founded in 1845, Scientific American is the oldest continuously published magazine in the US and the leading authoritative publication for science in the general media. Together with scientificamerican.com and 15 local language editions around the world it reaches over 3 million consumers and scientists. Other titles include Scientific American Mind and Spektrum der Wissenschaft in Germany.

Throughout all its businesses NPG is dedicated to serving the scientific and medical communities and the wider scientifically interested general public. Part of Macmillan Publishers Limited, NPG is a global company with principal offices in London, New York and Tokyo, and offices in cities worldwide including Boston, Buenos Aires, Delhi, Hong Kong, Madrid, Barcelona, Munich, Heidelberg, Basingstoke, Melbourne, Paris, San Francisco, Seoul and Washington DC. For more information, please go to www.nature.com.

Published: 18 Aug 2010

Contact details:

The Macmillan Building, 4 Crinan Street
London
N1 9XW
United Kingdom

+44 20 7833 4000
Country: 
Journal:
News topics: 
Content type: